Identifying potential tumor markers and antigens by database mining and rapid expression screening.
暂无分享,去创建一个
R. Strausberg | M. Marra | G. Riggins | A. Lal | I. Siu | D. Bigner | C. Prange | W. Loging | D D Bigner | C. Wikstrand | M A Marra | R L Strausberg | C Prange | W T Loging | A Lal | I M Siu | T L Loney | C J Wikstrand | G J Riggins | T. L. Loney | Marco A. Marra
[1] E. Sage,et al. The biology of SPARC, a protein that modulates cell‐matrix interactions , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] J. Siegfried,et al. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. , 1999, Pulmonary pharmacology & therapeutics.
[3] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[4] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[5] H. Moch,et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.
[6] L. Liotta,et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. , 1998, Trends in genetics : TIG.
[7] J. Craig Venter,et al. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library , 1993, Nature Genetics.
[8] S. Altschul,et al. A public database for gene expression in human cancers. , 1999, Cancer research.
[9] E. Sage,et al. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. , 1996, Seminars in cancer biology.
[10] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.
[11] C. Denef,et al. Expression of the genes encoding bombesin-related peptides and their receptors in anterior pituitary tissue , 1993, Molecular and Cellular Endocrinology.
[12] J. Greenfield,et al. The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. , 1999, Journal of cell science.
[13] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). , 1998, FEBS letters.
[14] E. Sprinzak,et al. Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. , 1999, Genome research.
[15] N. Ajubi,et al. nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts , 1995, International journal of cancer.
[16] S. Rempel,et al. SPARC: a potential diagnostic marker of invasive meningiomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] S. Walker,et al. Quantitative RT-PCR : Pitfalls and Potential , 1999 .
[18] J. Wu. Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene. , 1999, Annals of clinical and laboratory science.
[19] Y S Erozan,et al. Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Panchal,et al. Novel therapeutic strategies to selectively kill cancer cells. , 1998, Biochemical pharmacology.
[21] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[22] K. Kinzler,et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.
[23] Tumour serum markers: clinical and economical aspects. , 1996, Anticancer research.
[24] Itzhak D. Goldberg,et al. Regulation of Angiogenesis , 1996, Experientia Supplementum.
[25] E. Spindel,et al. Molecular cloning of cDNAs encoding the human bombesin-like peptide neuromedin B. Chromosomal localization and comparison to cDNAs encoding its amphibian homolog ranatensin. , 1988, The Journal of biological chemistry.
[26] T. B. Morrison,et al. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. , 1998, BioTechniques.
[27] C. Wittwer,et al. Continuous fluorescence monitoring of rapid cycle DNA amplification. , 1997, BioTechniques.
[28] O. Podhajcer,et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells , 1997, Nature Medicine.
[29] L. Bain,et al. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. , 1999, Cancer research.
[30] M. Trudeau,et al. Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[31] Carol A. Dahl,et al. New opportunities for uncovering the molecular basis of cancer , 1997, Nature Genetics.
[32] T. Mikkelsen,et al. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. , 1998, Journal of neuropathology and experimental neurology.
[33] Y. Sugiyama,et al. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .
[34] E. Gilboa,et al. Immunotherapy of cancer with dendritic-cell-based vaccines , 1998, Cancer Immunology, Immunotherapy.
[35] G. Landes,et al. Analysis of human transcriptomes , 1999, Nature Genetics.
[36] K. Kinzler,et al. Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Björck. Development of dendritic cells and their use in tumor therapy. , 1999, Clinical immunology.
[38] D. Avigan. Dendritic cells: development, function and potential use for cancer immunotherapy. , 1999, Blood reviews.
[39] R. Weinshilboum,et al. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. , 1994, The Journal of biological chemistry.
[40] J. Browning,et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity , 1986, Nature.
[41] P. Kleihues,et al. Primary and secondary glioblastomas: from concept to clinical diagnosis. , 1999, Neuro-oncology.
[42] D. K. Robson,et al. Pathology & Genetics. Tumours of the Nervous System. World Health Organisation Classification of Tumours. P. Kleihues and k. Cavenee (eds). IARC Press, Lyon, 2000. No. of pages: 314. ISBN: 92 832 2409 4 , 2001 .
[43] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Öbek,et al. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. , 1997, Cancer research.